FAQ: HeartBeam Inc.'s New Patents and 3D ECG Technology Advancements
Summary
HeartBeam Inc. has secured two new U.S. patents that enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology, advancing its innovative 3D ECG platform designed to transform cardiac care by enabling remote monitoring and diagnosis outside medical facilities.
What is the main topic of this announcement?
HeartBeam Inc. has secured two new U.S. patents that significantly enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology, specifically advancing its innovative 3D ECG platform.
Why are these new patents important for HeartBeam?
These patents add to HeartBeam’s growing IP portfolio, enabling the company to expand the reach and impact of its groundbreaking 3D ECG technology as it strives to transform the future of cardiac care.
How many patents does HeartBeam now hold?
HeartBeam now holds more than 20 U.S. and international patents, with additional applications pending, including 13 U.S. and 4 international-issued patents related to technology enablement.
What is HeartBeam’s 3D ECG technology designed to do?
The technology is designed to be the first-ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions, providing powerful cardiac insights wherever the patient is located.
Who is the CEO of HeartBeam and what is their vision?
Robert Eno is the CEO of HeartBeam, and his vision is to make it easier for patients and physicians to monitor and diagnose cardiac symptoms outside of a medical facility.
Where can patients use HeartBeam’s technology?
The technology is designed to be used in portable devices that can be used wherever the patient is, enabling cardiac monitoring and diagnosis outside of medical facilities.
What are the benefits of HeartBeam’s 3D ECG platform?
The platform allows physicians to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of medical facilities, redefining the future of cardiac health management.
Where can I find more information about HeartBeam Inc.?
For more information, visit www.HeartBeam.com or the company’s newsroom at https://ibn.fm/BEAT for the latest news and updates.
What is BioMedWire and its role in this announcement?
BioMedWire is a specialized communications platform focused on biotechnology and biomedical sciences that published this article and provides distribution services through the InvestorBrandNetwork.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 172590